APLLTD — Alembic Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- IN₹149.41bn
- IN₹161.55bn
- IN₹73.45bn
Brief: Alembic Pharmaceuticals Gets US FDA Tentative Approval For Selexipag For Injection
Brief: Alembic Pharmaceuticals Gets US FDA Nod For Bromfenac Ophthalmic Solution, 0.07%
India's Alembic Pharmaceuticals rises on US FDA's tentative approval for Ivosidenib tablets
Brief: Alembic Pharmaceuticals Gets US FDA Tentative Nod For Ivosidenib Tablets 250 Mg
Brief: Alembic Pharmaceuticals Got 11 US FDA Product Approvals During June-Quarter
India's Alembic Pharmaceuticals up on US drug regulator approval for leukemia tablets
Brief: Alembic Pharmaceuticals Gets US FDA Tentative Approval For Bosutinib Tablets 100 Mg, 500 Mg
Brief: Alembic Pharmaceuticals Gets USFDA Final Approval For Icatibant Injection 30 MG/3ML Single Dose Prefilled Syringe
India's Solara Active Pharma up after USFDA inspection ends
India's Alembic Pharma posts higher Q4 profit on strong N.America sales
Brief: Alembic Pharmaceuticals Says Got Tax Order For Demand Of 3.3 Million Rupees, Interest 3 Million Rupees
Brief: Alembic Pharmaceuticals Gets GST Orders Imposing Total Penalty Of 11.7 Mln Rupees
India's Alembic Pharma up on US FDA approval for cancer product
Brief: Alembic Pharmaceuticals Got One USFDA Product Approval (Tentative) During Qtr Ended March 31
Brief: Alembic Pharmaceuticals Gets Penalty Of 3 Mln Rupees
India's Alembic Pharma falls after US FDA scrutiny
Brief: Alembic Pharmaceuticals Says USFDA Issues Form 483 With 4 Observations After Inspection
Brief: Alembic Pharmaceuticals Fully Resumes Its Manufacturing Operations At Namthang Manufacturing Facility
India's Alembic Pharma hits over 3-year high